Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium channel protein Cch1 is a fungal-specific integral membrane protein that functions as the pore-forming subunit of the high-affinity calcium uptake system (HACS) [1][2]. It is a structural and functional homolog of the alpha-1 subunit found in mammalian voltage-gated calcium channels, although it exhibits distinct regulatory properties and sequence variations [3]. Cch1 operates in a complex with the regulatory protein Mid1 to mediate calcium influx in response to various environmental stressors, including alkaline pH, cold stress, and low calcium availability [4]. In pathogenic fungi such as Candida albicans and Cryptococcus neoformans, Cch1 is a critical factor for virulence, survival within the host environment, and the development of resistance to antifungal drugs [4][5]. Because of its essential role in fungal physiology and its divergence from human calcium channels, Cch1 is considered a promising target for the development of novel, non-toxic antifungal therapeutics [5][6]. Inhibition of Cch1 disrupts vital calcium-dependent signaling pathways, such as the calcineurin-Crz1 pathway, which leads to impaired cell wall integrity and increased susceptibility to existing antifungal agents like azoles [6][7]. Research has shown that various classical calcium channel blockers, such as Verapamil, can inhibit Cch1-mediated calcium entry, providing a template for the design of more selective fungal calcium channel inhibitors [5][8]. [1] UniProt (P53048); [2] Paidhungat, M. & Garrett, S. (1997) PMID: 9381187; [3] Peiter, E., et al. (2005) PMID: 16166549; [4] Liu, S., et al. (2015) PMID: 26038221; [5] Edlind, T. D., et al. (2002) PMID: 12384351; [6] Teng, L., et al. (2013) PMID: 23610427; [7] Cyert, M. S. (2003) PMID: 12783569; [8] Yu, Q., et al. (2014) PMID: 25150596.
Inhibition of calcium influx through the high-affinity calcium uptake system (HACS) to disrupt calcium-dependent signaling pathways essential for fungal growth and virulence.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium channel protein Cch1 (Cch1).